GO:1903084 protein localization to condensed nuclear chromosome: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903084 describes the biological process by which proteins are transported to, or maintained within, a condensed nuclear chromosome.
• This process is driven largely by biomolecular condensation and phase separation, which concentrate proteins on mitotic or meiotic chromosomes.
• Key proteins include condensate-forming factors such as ARID1A, FOXA1, YAP, Xist, and cBAF complex subunits.
• Disruption of protein localization to condensed chromosomes is linked to cancers such as Ewing sarcoma and to defects in X-chromosome inactivation.
• CRISPR knockout, knock-in, and overexpression models are essential to test how specific domains control chromosomal protein targeting.
• Advanced imaging, proteomics, and phase-separation assays are the primary methods used to study this process.
Description
Protein localization to condensed nuclear chromosome (GO:1903084) is a biological process in which proteins are actively transported to, or retained at, specific locations within a condensed nuclear chromosome. Condensed chromosomes occur during mitosis and meiosis, when chromatin becomes tightly packaged, and also in specialized contexts such as the inactive X chromosome. Understanding how proteins find and stay on these compacted structures is fundamental to chromosome segregation, gene regulation, and genome stability. Recent evidence indicates that many chromosomal proteins use liquid-liquid phase separation to concentrate on condensed chromatin, forming biomolecular condensates that can reorganize genome topology. For example, the cBAF chromatin remodeling complex relies on a disordered region to condense and recruit partners to mitotic chromosomes. Similarly, Xist RNA spreads along the inactive X chromosome through biophysical mechanisms that limit diffusion and maintain protein localization. These findings place GO:1903084 at the intersection of phase separation, chromatin biology, and disease. Researchers studying this process need precise tools to perturb candidate genes and measure protein localization on condensed chromosomes, making CRISPR-based models indispensable.
protein localization to condensed nuclear chromosome At A Glance
| GO ID | GO:1903084 |
|---|---|
| GO term | protein localization to condensed nuclear chromosome |
| Ontology | biological_process |
| Synonym | protein localisation in condensed nuclear chromosome; protein localisation to condensed nuclear chromosome; protein localization in condensed nuclear chromosome |
| Major function | Transport and retention of proteins on condensed nuclear chromosomes |
| Related processes | Chromosome condensation, phase separation, chromatin remodeling, X-chromosome inactivation |
| Key cellular context | Mitosis, meiosis, inactive X chromosome |
| Disease relevance | Cancer, developmental disorders, X-linked diseases |
What Is GO:1903084?
According to the Gene Ontology, GO:1903084 is defined as a process in which a protein is transported to, or maintained in, a location within a condensed nuclear chromosome. This includes both the active delivery of proteins to compacted chromosomal regions and the mechanisms that keep them there once they arrive. The term is a biological process and applies to events occurring on condensed nuclear chromosomes, such as those seen during mitosis, meiosis, or X-chromosome inactivation.
Why Is protein localization to condensed nuclear chromosome Important in Cell Biology?
Protein localization to condensed nuclear chromosomes is essential for faithful chromosome segregation, proper gene silencing, and maintenance of genome integrity. When this process fails, proteins may mislocalize, leading to chromosomal instability and diseases such as cancer. The growing recognition that phase separation drives this localization has opened new avenues for therapeutic intervention, particularly in cancers driven by condensate-forming oncoproteins like ARID1A. Moreover, understanding how proteins are maintained on condensed chromosomes informs basic mechanisms of epigenetic inheritance and X-chromosome inactivation.
• Ensures proper chromosome segregation during mitosis and meiosis.
• Controls gene silencing on the inactive X chromosome through Xist-mediated localization.
• Regulates chromatin remodeling complexes such as cBAF on condensed chromosomes.
• Influences oncogenic potential in Ewing sarcoma via ARID1A phase separation.
• Impacts pioneer factor function, as FOXA1 condensates unpack condensed chromatin.
• Modulates genome topology and long-term gene expression through YAP phase separation.
• Provides a mechanism for endogenous retroviruses to hijack transcriptional condensates.
• Offers targets for therapeutic disruption of pathological condensates in cancer.
• Reveals biophysical principles of chromatin viscoelasticity and locus repositioning.
• Highlights intrinsic material properties of chromatin condensates in diverse conditions.
What Happens During protein localization to condensed nuclear chromosome?
Initiation by phase separation
In simple terms: Proteins clump together into droplets on condensed chromosomes.
Many proteins that localize to condensed nuclear chromosomes contain intrinsically disordered regions that drive liquid-liquid phase separation. For instance, the cBAF complex subunit ARID1A forms condensates through its prion-like domain, which is necessary for its oncogenic function in Ewing sarcoma. Similarly, YAP phase separation reorganizes genome topology to sustain long-term target gene expression. This condensation step concentrates proteins at specific chromosomal locations, effectively initiating their localization.
Transport and targeting to condensed chromosomes
In simple terms: Proteins are carried to the right spot on the chromosome.
Once condensates form, proteins must be transported to condensed nuclear chromosomes. Biophysical studies show that condensate interfacial forces can reposition DNA loci and probe chromatin viscoelasticity, suggesting an active transport mechanism. Xist RNA, which coats the inactive X chromosome, exhibits limited diffusion and spreading behavior that depends on its biophysical properties, ensuring proteins are delivered along the chromosome. This step often requires specific targeting domains or partner recruitment, as seen with cBAF activity controlled by a disordered region.
Retention and maintenance on condensed chromosomes
In simple terms: Proteins stick to the chromosome and stay there.
After delivery, proteins must be maintained on condensed chromosomes. Intrinsic chromatin condensates have liquid-like material properties that allow dynamic exchange while retaining proteins. FOXA1 forms biomolecular condensates that unpack condensed chromatin to function as a pioneer factor, illustrating how retention can lead to chromatin remodeling. In the context of Xist, the limited diffusion of the RNA-protein complex ensures stable localization on the inactive X. Disruption of retention mechanisms can lead to protein mislocalization and disease.
Regulation by partner recruitment and post-translational modifications
In simple terms: Other molecules help decide which proteins stay on the chromosome.
Partner recruitment modulates protein localization to condensed chromosomes. For example, the disordered region of cBAF controls its activity via condensation and partner recruitment. Endogenous retroviruses can hijack transcriptional condensates, altering the localization of transcription factors on condensed chromatin. Post-translational modifications and cofactors likely fine-tune these interactions, though specific mechanisms remain an active area of research.
Key Genes Involved in GO:1903084 protein localization to condensed nuclear chromosome
The following genes and proteins are experimentally implicated in protein localization to condensed nuclear chromosomes, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ARID1A | Phase separation via prion-like domain; cBAF subunit | Oncogenic potential in Ewing sarcoma |
| FOXA1 | Forms condensates that unpack condensed chromatin | Pioneer factor function |
| YAP | Phase separation reorganizes genome topology | Long-term target gene expression |
| Xist | Spreading and limited diffusion on inactive X | X-chromosome inactivation |
| cBAF complex | Disordered region controls condensation and partner recruitment | Chromatin remodeling on mitotic chromosomes |
| SMARCA4 | cBAF subunit, ATPase | Chromatin remodeling |
| SMARCB1 | cBAF subunit | Chromatin remodeling |
| CTCF | Chromatin organizer | Genome topology |
| H3K27me3 | Repressive histone mark | X inactivation |
| EZH2 | Polycomb repressive complex 2 subunit | Chromatin condensation |
| BRD4 | Transcriptional condensate component | Endogenous retrovirus hijacking |
| MED1 | Mediator subunit in condensates | Transcriptional regulation |
| HP1 | Heterochromatin protein | Chromosome condensation |
| LBR | Nuclear envelope protein | Chromatin condensation |
| TOP2A | DNA topoisomerase | Chromosome condensation |
| SMC2 | Condensin subunit | Chromosome condensation |
| SMC4 | Condensin subunit | Chromosome condensation |
How Is protein localization to condensed nuclear chromosome Regulated?
The process of protein localization to condensed nuclear chromosomes is regulated by phase separation propensity, partner recruitment, and biophysical properties of chromatin. Disordered regions in proteins such as ARID1A and cBAF subunits control condensation and recruitment, thereby regulating localization. Xist spreading is limited by diffusion and depends on its biophysical characteristics. Additionally, endogenous retroviruses can hijack transcriptional condensates, altering the regulatory landscape. These regulatory layers ensure that proteins localize correctly to condensed chromosomes during mitosis, meiosis, and X inactivation.
protein localization to condensed nuclear chromosome and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ARID1A | Ewing sarcoma | Knockout and point mutation of prion-like domain |
| YAP | Cancer (multiple types) | Overexpression and phase separation mutants |
| Xist | X-linked diseases | Knock-in of tagged Xist for imaging |
| FOXA1 | Developmental disorders | Knockout and condensate-disrupting mutations |
| cBAF subunits | Cancer, Coffin-Siris syndrome | Knockout of disordered region |
Cancer
Dysregulation of protein localization to condensed nuclear chromosomes contributes to cancer. ARID1A phase separation via its prion-like domain promotes oncogenic potential in Ewing sarcoma, and disrupting this condensation may reduce tumor growth. YAP phase separation reorganizes genome topology to sustain long-term oncogenic gene expression. These findings suggest that targeting condensate formation could be a therapeutic strategy in cancers dependent on chromosomal protein localization.
X-linked diseases
Proper localization of Xist and associated proteins to the inactive X chromosome is critical for X-chromosome inactivation. Defects in Xist spreading or retention can lead to skewed X inactivation and X-linked diseases. The biophysical basis for Xist spreading and limited diffusion has been characterized, providing insights into how mutations might disrupt this process.
Developmental disorders
Pioneer factors like FOXA1 form condensates that unpack condensed chromatin to initiate developmental gene programs. Disruption of FOXA1 condensation could impair lineage specification and contribute to developmental disorders, though direct evidence in human disease is still emerging.
From protein localization to condensed nuclear chromosome-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does ARID1A phase separation drive Ewing sarcoma? | ARID1A knockout and point mutation (prion-like domain) |
| How does YAP condensation affect genome topology? | YAP overexpression and knockout |
| What is the role of Xist diffusion in X inactivation? | Xist knock-in with tags for live imaging |
| Does FOXA1 condensate formation require specific domains? | FOXA1 knockout and knock-in of mutant alleles |
| How does cBAF disordered region control localization? | cBAF subunit knockout and rescue with domain deletions |
| Do endogenous retroviruses hijack transcriptional condensates? | Overexpression of retroviral elements and BRD4 knockout |
How to Study the protein localization to condensed nuclear chromosome Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Protein localization dynamics on condensed chromosomes | Tracking GFP-tagged proteins during mitosis |
| FRAP | Liquid-like properties of condensates | Assessing material state of chromatin condensates |
| In vitro phase separation | Condensate formation by purified proteins | Testing ARID1A prion-like domain |
| Proximity labeling (BioID) | Protein-protein interactions at chromosomes | Identifying cBAF partners |
| ChIP-seq | Chromatin binding sites | Mapping FOXA1 on condensed chromatin |
| RNA-seq | Gene expression changes | Measuring YAP target genes |
| Hi-C | Genome topology | Assessing YAP-mediated reorganization |
| Single-molecule tracking | Diffusion of Xist | Characterizing Xist spreading |
Imaging of protein localization on condensed chromosomes
Live-cell imaging and fluorescence microscopy are essential to visualize protein localization to condensed nuclear chromosomes. Tagged proteins (e.g., GFP fusions) can be tracked during mitosis or on the inactive X chromosome. Advanced techniques such as single-molecule tracking reveal diffusion properties of Xist. These methods allow researchers to quantify accumulation and retention on condensed chromosomes.
Phase separation assays
In vitro phase separation assays using purified proteins or domains can determine whether a protein undergoes liquid-liquid phase separation. For example, the prion-like domain of ARID1A forms condensates in vitro, and mutations that disrupt this affect oncogenic potential. Similar assays for cBAF subunits and YAP have elucidated condensation mechanisms. These assays are often combined with fluorescence recovery after photobleaching (FRAP) to measure liquid-like properties.
Proteomics and interactomics
Mass spectrometry-based proteomics can identify proteins that localize to condensed chromosomes. Chromosome fractionation followed by immunoprecipitation or proximity labeling (e.g., BioID) reveals partner recruitment. For instance, cBAF partner recruitment is controlled by its disordered region, which can be mapped by interactomics. These approaches provide unbiased identification of components in the localization process.
Genome-wide and transcriptomic methods
RNA-seq and ChIP-seq can assess the consequences of protein localization on gene expression and chromatin state. YAP phase separation alters genome topology and long-term target gene expression, which can be measured by RNA-seq and Hi-C. Xist spreading can be mapped by RNA FISH and chromatin capture techniques. These methods link localization to functional outcomes.
How CRISPR Can Be Used to Study GO:1903084 protein localization to condensed nuclear chromosome
Knockout
CRISPR knockout of genes such as ARID1A, YAP, or cBAF subunits allows researchers to test whether they are required for protein localization to condensed chromosomes. For example, ARID1A knockout reduces Ewing sarcoma oncogenic potential, demonstrating its essential role. Knockout of cBAF subunits disrupts chromatin remodeling on mitotic chromosomes. These models provide loss-of-function evidence for causality.
Point Mutation
Point mutations can dissect specific domains responsible for localization. Mutating the prion-like domain of ARID1A abolishes phase separation and reduces oncogenic potential. Similarly, point mutations in FOXA1 condensate-forming regions impair its pioneer factor function. These precise edits reveal structure-function relationships without deleting the entire gene.
Knock-in
Knock-in of tagged alleles (e.g., GFP or HaloTag) enables real-time imaging of protein localization on condensed chromosomes. Tagged Xist knock-in mice have been used to study Xist spreading and diffusion. Knock-in of disease-associated mutations can model human disorders affecting chromosomal protein localization.
Overexpression
Overexpression of wild-type or mutant proteins can test sufficiency for localization. YAP overexpression drives genome reorganization and target gene expression. Overexpression of endogenous retroviral elements hijacks transcriptional condensates, altering protein localization. These models are useful for gain-of-function studies.
How EDITGENE Supports protein localization to condensed nuclear chromosome Research
Researchers studying protein localization to condensed nuclear chromosome-related genes often need to determine whether a candidate gene is causally involved in the process or is merely correlated with it. CRISPR-based models provide the gold standard for establishing causality by enabling precise genetic perturbations.
Contact EDITGENE today to design your custom CRISPR model for protein localization to condensed nuclear chromosome research.
Frequently Asked Questions About protein localization to condensed nuclear chromosome
What is protein localization to condensed nuclear chromosome?
It is the biological process (GO:1903084) by which proteins are transported to or maintained within a condensed nuclear chromosome, often driven by phase separation.
What genes are involved in protein localization to condensed nuclear chromosome?
Key genes include ARID1A, FOXA1, YAP, Xist, and cBAF complex subunits such as SMARCA4 and SMARCB1.
How does phase separation relate to protein localization on condensed chromosomes?
Phase separation concentrates proteins into condensates that target and retain them on condensed chromosomes, as shown for ARID1A, YAP, and cBAF.
What diseases are linked to defects in protein localization to condensed nuclear chromosomes?
Cancers such as Ewing sarcoma, X-linked diseases, and developmental disorders have been linked to defects in this process.
What methods are used to study protein localization to condensed nuclear chromosomes?
Live-cell imaging, FRAP, in vitro phase separation, proteomics, ChIP-seq, RNA-seq, and Hi-C are commonly used.
How can CRISPR help study protein localization to condensed nuclear chromosomes?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise perturbation of candidate genes to test causality.
What is the role of Xist in protein localization to condensed nuclear chromosome?
Xist spreads along the inactive X chromosome with limited diffusion, recruiting proteins to maintain localization.
Can condensates be targeted therapeutically in cancers driven by chromosomal protein mislocalization?
Yes, disrupting condensate formation, such as ARID1A phase separation, is a potential therapeutic strategy in Ewing sarcoma.
What is the difference between protein localization to condensed nuclear chromosome and chromatin condensation?
Chromatin condensation is the packaging of DNA, while GO:1903084 specifically describes the transport and retention of proteins on already condensed chromosomes.
Which model organisms are used to study protein localization to condensed nuclear chromosomes?
Human cell lines, mouse models (e.g., Xist knock-in), and in vitro systems are commonly used.
Conclusion
Protein localization to condensed nuclear chromosome (GO:1903084) is a fundamental biological process that ensures proteins reach and remain on compacted chromosomes during mitosis, meiosis, and X inactivation. Driven by phase separation and partner recruitment, this process is critical for genome stability and gene regulation. Its dysregulation is implicated in cancers such as Ewing sarcoma and in X-linked diseases. Continued research using CRISPR models and advanced imaging will unravel the precise mechanisms and therapeutic opportunities.
References
- 1. Patil A et al.. 2023. A disordered region controls cBAF activity via condensation and partner recruitment.. Cell 186(22):4936-4955.e26 PMID: 37788668
- 2. Ji D et al.. 2024. FOXA1 forms biomolecular condensates that unpack condensed chromatin to function as a pioneer factor.. Mol Cell 84(2):244-260.e7 PMID: 38101414
- 3. Cai D et al.. 2019. Phase separation of YAP reorganizes genome topology for long-term YAP target gene expression.. Nat Cell Biol 21(12):1578-1589 PMID: 31792379
- 4. Ding M et al.. 2025. A biophysical basis for the spreading behavior and limited diffusion of Xist.. Cell 188(4):978-997.e25 PMID: 39824183
- 5. Asimi V et al.. 2022. Hijacking of transcriptional condensates by endogenous retroviruses.. Nat Genet 54(8):1238-1247 PMID: 35864192
- 6. Strom AR et al.. 2024. Condensate interfacial forces reposition DNA loci and probe chromatin viscoelasticity.. Cell 187(19):5282-5297.e20 PMID: 39168125
- 7. Gibson BA et al.. 2023. In diverse conditions, intrinsic chromatin condensates have liquid-like material properties.. Proc Natl Acad Sci U S A 120(18):e2218085120 PMID: 37094140
- 8. Kim YR et al.. 2024. Prion-like domain mediated phase separation of ARID1A promotes oncogenic potential of Ewing's sarcoma.. Nat Commun 15(1):6569 PMID: 39095374
